1 Min Read
* BioPharmx reports second quarter 2018 financial results
* Q2 loss per share $0.05
* Q2 earnings per share view $-0.06 — Thomson Reuters I/B/E/S
* Q2 non-GAAP loss per share $0.05 excluding items Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.